Characterization of ZAG protein expression in prostate cancer using a semi-automated microscope system

Prostate

Volumn 66, Issue 10, 2006, Pages 1037-1043

  Descazeaud, Aurelien ^a,b,c   De La Taille, Alexandre ^a   Allory, Yves ^a   Faucon, Hugo ^a   Salomon, Laurent ^a   Bismar, Tarek ^b,c   Kim, Robert ^b,c   Hofer, Matthias D ^b,c   Chopin, Dominique ^a   Abbou, Claude C ^a   Rubin, Mark A ^b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AZGP1; Prostate; Prostate carcinoma; Protein expression; Tissue microarrays; ZAG

Indexed keywords

ALPHA2 GLYCOPROTEIN; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN 1;

ADIPOCYTE; ADULT; AGED; ARTICLE; AUTOMATION; CANCER STAGING; CANCER SURGERY; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LIPID DEGRADATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROSCOPY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION; TISSUE MICROARRAY; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; AUTOMATION; CARRIER PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 33745295638     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20405     Document Type: Article

References (18)

1. Burgi W, Schmid K. Preparation and properties of Zn-alpha 2-glycoprotein of normal human plasma. J Biol Chem 1961;236:1066-1074.
2. Tada T, Ohkubo I, Niwa M, Sasaki M, Tateyama H, Eimoto T. Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. J Histochem Cytochem 1991;39(9):1221-1226.
3. Freije JP, Fueyo A, Uria J, Lopez-Otin C. Human Zn-alpha 2-glycoprotein cDNA cloning and expression analysis in benign and malignant breast tissues. FEBS Lett 1991;290(1-2):247-249.
4. Poortmans JR, Schmid K. The level of Zn-alpha 2-glycoprotein in normal human body fluids and kidney extract. J Lab Clin Med 1968;71(5):807-811.
5. Jirka M, Blanicky P, Srajer J, Zwinger A, Jirasek JE. Human serum Zn-alpha2-glycoprotein in amniotic fluid. Clin Chim Acta 1978; 85(2):107-110.
6. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S, et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 2004;101(8):2500-2505.
7. Tisdale MJ. Tumor-host interactions. J Cell Biochem 2004;93(5):871-877.
8. Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA 2004; 101(3):811-816.
9. Hale LP, Price DT, Sanchez LM, Demark-Wahnefried W, Madden JF. Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin Cancer Res 2001;7(4):846-853.
10. Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, et al. Alpha-methylacyl-CoA racemase: A new molecular marker for prostate cancer. Cancer Res 2002;62(8):2220-2226.
11. Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, et al. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. Jama 2002;287(13):1662-1670.
12. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002; 419(6907):624-629.
13. Bauer KD, de la Torre-Bueno J, Diel IJ, Hawes D, Decker WJ, Priddy C, et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. Clin Cancer Res 2000;6(9):3552-3559.
14. Hilbe W, Gachter A, Duba HC, Dirnhofer S, Eisterer W, Schmid T, et al. Comparison of automated cellular imaging system and manual microscopy for immunohistochemically stained cryostat sections of lung cancer specimens applying p53, ki-67 and p120. Oncol Rep 2003;10(1):15-20.
15. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, et al. P504S: A new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001;25(11):1397-1404.
16. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167(2 Pt 1):528-534.
17. Etzioni R, Kooperberg C, Pepe M, Smith R, Gann PH. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics 2003;4(4):523-538.
18. Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 2003;95(9):634-635.